Pakistan vs Togo: The number of people with susceptibility test result for rifampicin
Pakistan
91.93
in 2021
Togo
92.42
in 2021
Pakistan rank
63rd
Togo rank
61st
The number of people with susceptibility test result for rifampicin over time
- Pakistan
- Togo
How they compare
Togo currently reports 92.42 against 91.93 in Pakistan, a difference of 0.49.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Pakistan ahead.
Pakistan ranks 63rd and Togo ranks 61st of 146 countries.
Across the 2 decades both report, Pakistan averaged higher in 1 and Togo in 1.
Head to head by decade
| Decade | Pakistan | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 43.98 | 36.81 | 7.17 | Pakistan |
| 2020s | 81.25 | 90.74 | 9.5 | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Pakistan or Togo?
- Togo, at 92.42 against 91.93 in Pakistan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Pakistan and Togo?
- 0.49, with Togo ahead.
- How many years of comparable data are there for Pakistan and Togo?
- 5 years are reported by both, from 2017 to 2021.
- How do Pakistan and Togo rank globally for the number of people with susceptibility test result for rifampicin?
- Pakistan ranks 63rd and Togo ranks 61st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.